Glenn Reicin

Glenn Reicin

61 Jahre
Finance
Health Technology
Consumer Services

Profil

Glenn M.
Reicin
is Chief Financial Officer at Harmony Biosciences Holdings, Inc. since 2026.
Former roles include Chief Financial Officer & Treasurer at Sigilon Therapeutics, Inc. from 2019 to 2021; President at Greyrock Biomedical Advisors Ltd. from 2013 to 2019; Director at Novasys Medical, Inc. from 2009 to 2013; Director at SpinalMotion, Inc. from 2009 to 2014; Director at SI-BONE, Inc. from 2010 to 2012; Managing Director at Morgan Stanley & Co. LLC from 1993 to 2008; Managing Director at Skyline Management LLC from 2009 to 2012; Independent Director at Amplitude Healthcare Acquisition Corp.; Analyst at Fidelity Management & Research Co. LLC; Senior Vice President at Oppenheimer & Co., Inc.; Management Consultant at Bain & Co., Inc.; and Chief Financial & Operating Officer at Alladapt Immunotherapeutics, Inc. Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.

Aktive Positionen von Glenn Reicin

UnternehmenPositionBeginn
HARMONY BIOSCIENCES HOLDINGS, INC. Finanzdirektor/CFO 14.04.2026

Ehemalige bekannte Positionen von Glenn Reicin

UnternehmenPositionEnde
SIGILON THERAPEUTICS, INC. Finanzdirektor/CFO 14.06.2021
Präsident 01.05.2019
Direktor/Vorstandsmitglied 01.01.2014
Direktor/Vorstandsmitglied 01.01.2013
Private Equity Investor 01.01.2012
Sehen Sie sich die Erfahrung von Glenn Reicin im Detail an

Ausbildung von Glenn Reicin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

97

Beziehungen ersten Grades

15

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen15

Finance

Finance

Health Services

Health Technology

Health Technology

Finance

Commercial Services

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Finance

Health Technology

  1. Börse
  2. Insiders
  3. Glenn Reicin